{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:08:27Z","timestamp":1766182107044,"version":"3.41.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate predictors of recurrent exudation in choroidal neovascularization (CNV) of pachychoroid neovasculopathy after photodynamic therapy (PDT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Consecutive, treatment-na\u00efve, symptomatic patients with pachychoroid neovasculopathy with subfoveal retinal fluid treated with PDT and followed for 18 months were studied retrospectively. Choroidal neovascularization areas were calculated from optical coherence tomography angiography images obtained at various time points after the initial PDT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In 52 eyes, the subfoveal retinal fluid resolved completely three months after PDT; in 23 (44%) eyes, exudation recurred during the 18-month follow-up period. In 29 eyes with no recurrence, the mean baseline square root of the CNV area of 1.91 mm (95% CI, 0.27) decreased significantly (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006) to 1.47 mm (95% CI, 0.16) at three months after PDT and decreased further until 12 months after PDT (mean, 1.26 mm; 95% CI, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and was maintained thereafter. In 23 eyes with a recurrence, the square root of the CNV area enlarged significantly (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.028) from 1.43 mm (95% CI, 0.21) at examination three months before the recurrence to 1.73 mm (95% CI, 0.18) at recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Choroidal neovascularization enlargement during the follow-up period after PDT for pachychoroid neovasculopathy may predict recurrence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003841","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:00:49Z","timestamp":1684962049000},"page":"1495-1503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["ENLARGEMENT OF CHOROIDAL NEOVASCULARIZATION BEFORE RECURRENCE AFTER PHOTODYNAMIC THERAPY FOR PACHYCHOROID NEOVASCULOPATHY"],"prefix":"10.1097","volume":"44","author":[{"given":"Taiichi","family":"Hikichi","sequence":"first","affiliation":[{"name":"Hikichi Eye Clinic, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Kubo","sequence":"additional","affiliation":[{"name":"Hikichi Eye Clinic, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Tabata","sequence":"additional","affiliation":[{"name":"Hikichi Eye Clinic, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Kurabe","sequence":"additional","affiliation":[{"name":"Hikichi Eye Clinic, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10384-020-00740-5","article-title":"Pachychoroid disease: a new perspective on exudative maculopathy","volume":"64","author":"Yanagi","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00417-020-04940-0","article-title":"Pachychoroid: current concepts on clinical features and pathogenesis","volume":"259","author":"Castro-Navarro","year":"2021","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/02713683.2021.1942073","article-title":"Pachychoroid spectrum disease: underlying pathology, classification, and phenotypes","volume":"46","author":"Hua","year":"2021","journal-title":"Cur Eye Res"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"89","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oret.2018.08.008","article-title":"Clinicopathologic correlation of aneurysmal type 1 neovascularization in age-related macular degeneration","volume":"3","author":"Li","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41598-019-38504-y","article-title":"Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy","volume":"9","author":"Jung","year":"2019","journal-title":"Sci Rep"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10384-018-0562-0","article-title":"Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and type 1 neovascular age-related macular degeneration","volume":"62","author":"Matsumoto","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IAE.0000000000000809","article-title":"One-year results of adjunctive photodynamic therapy for type 1 neovascularization associated with thickened choroid","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/eye.2016.41","article-title":"Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy","volume":"30","author":"Smretschnig","year":"2016","journal-title":"Eye"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3390\/jcm10102168","article-title":"Two-thirds dose photodynamic therapy for pachychoroid neovasculopathy","volume":"10","author":"Tanaka","year":"2021","journal-title":"J Clin Med"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/ph15040483","article-title":"One-year outcome of combination therapy with full or reduced photodynamic therapy and one anti-vascular endothelial growth factor in pachychoroid neovasculopathy","volume":"15","author":"Sato-Akushichi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"R15-20250605","first-page":"286","article-title":"3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization","volume":"11","author":"Hu","year":"2022","journal-title":"Sci Rep"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1038\/s41433-021-01418-z","article-title":"One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroidal neovasculopathy","volume":"35","author":"Hikichi","year":"2021","journal-title":"Eye (Lond)"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/IAE.0000000000002745","article-title":"Predictors of recurrent exudation in choroidal neovascularization in age-related macular degeneration during a treatment-free period","volume":"40","author":"Hikichi","year":"2020","journal-title":"Retina"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"16204","DOI":"10.1038\/srep16204","article-title":"Pachychoroid neovasculopathy and age-related macular degeneration","volume":"5","author":"Miyake","year":"2015","journal-title":"Sci Rep"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1","volume":"117","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ophtha.2017.02.006","article-title":"Impact of multiple en face image averaging on quantitative assessment from optical coherence tomography angiography images","volume":"124","author":"Uji","year":"2017","journal-title":"Ophthalmology"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1167\/iovs.18-24522","article-title":"Reduced vessel density of the choriocapillaris during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"60","author":"Hikichi","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaophthalmol.2016.3519","article-title":"Histopathological insights into choroidal vascular loss in clinically documented cases of age-related macular degeneration","volume":"134","author":"Seddon","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R24-20250605","first-page":"830","article-title":"Photodynamic effects on choroidal neovascularization and physiological choroid","volume":"43","author":"Schmidt-Erfurth","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.oret.2018.01.014","article-title":"Quantitative evaluation of choroidal neovascularization under pro re nata anti-vascular endothelial growth factor therapy with OCT angiography","volume":"2","author":"McClintic","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-VIP Report 2","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archopht.121.9.1253","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report No. 2","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R28-20250605","first-page":"1171","article-title":"Retrospective studies and chart reviews","volume":"49","author":"Hess","year":"2004","journal-title":"Respir Care"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/IAE.0000000000000765","article-title":"Image artifacts in optical coherence tomography angiography","volume":"35","author":"Spaide","year":"2015","journal-title":"Retina"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1364\/BOE.398222","article-title":"OCT-OCTA segmentation: combining structural and blood flow information to segment Bruch's membrane","volume":"12","author":"Schottenhamml","year":"2021","journal-title":"Biomed Opt Express"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:02:26Z","timestamp":1749142946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003841","relation":{},"ISSN":["0275-004X"],"issn-type":[{"type":"print","value":"0275-004X"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}